NCGR, Aiming to Diversify Platforms, Acquires Five SOLiD 4 Instruments

NCGR has been exclusively using the Illumina Genome Analyzer as its next-generation sequencing platform. Adding the SOLiD machines is part of a strategy to diversify the center's offerings.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.